You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Create a customized SOLUTION that has been shown to reduce exposure to radiation.
The TRUFILL™ n-BCA Liquid Embolic System is used under fluoroscopic guidance to obstruct or reduce blood flow to cerebral arteriovenous malformations (AVMs) via super-selective catheter delivery when pre-surgical devascularization is desired.
Lower Incidence of Microcatheter Retention
1.6% (1/63) rate of microcatheter retention with TRUFILL™ n-BCA compared to 9.3% (5/54) with ONYX™ LES.
Significant Reduction in Fluoroscopy
TRUFILL™ n-BCA has been shown to require on average 71 fewer minutes of fluoroscopy time per patient than ONYX™ LES (135 +/- 65 min vs. 64 +/- 55 min).
Lower Total Procedural Costs
TRUFILL™ n-BCA does not require the use of expensive detachable tip microcatheters or dual lumen balloon catheters.
Related Products
ENVOY
CERENOVUS Coil Portfolio
NEUROSCOUT® Steerable Guidewire
Specification
| Product Code | Kit Name | Contents |
|---|---|---|
| 631500 | TRUFILL™ n-BCA Liquid Embolic System 1 Gram Kit | One - 1 Gram TRUFILL™ n-BCA n-Butyl Cyanoacrylate, One - 10mL TRUFILL™ Ethiodized Oil, One - 1 Gram TRUFILL™ Tantalum Powder and One Self-piercing Cap. |
| 631400 | TRUFILL™ n-BCA Liquid Embolic System 2 Gram Kit | Contents: Two - 1 Gram TRUFILL™ n-BCA n-Butyl Cyanoacrylate, One - 10mL TRUFILL™ Ethiodized Oil, One - 1 Gram TRUFILL™ Tantalum Powder and Two Self-piercing Caps. |
References
196727-211123
Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions.
Caution: US law restricts this device to sale by or on the order of a physician
This site is published by CERENOVUS which is solely responsible for its contents. It is intended for visitors from the United States.
© CERENOVUS 2022 Last Updated on 05/09/2022